Targeting the MYC pathway to treat cancer
Targeting the MYC Pathway for the Treatment of Cancer
This study is looking for new ways to treat cancers that rely on a gene called MYC, which often helps tumors grow, and it's designed for people affected by these types of cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11044345 on NIH RePORTER |
What this research studies
This research focuses on developing new therapies that specifically target the MYC oncogene pathway, which is commonly activated in various human cancers. The principal investigator has extensive experience in understanding how MYC contributes to tumor growth and maintenance. By utilizing innovative techniques, including conditional transgenic mouse models, the research aims to explore both intrinsic tumor mechanisms and host-immune interactions. The ultimate goal is to create effective treatments for cancers that are dependent on the MYC oncogene.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancers that are known to be driven by the MYC oncogene.
Not a fit: Patients with cancers not associated with the MYC pathway may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking therapies for patients with MYC-driven cancers.
How similar studies have performed: Previous research has shown promising results in targeting oncogenes, indicating potential for success in this novel approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Felsher, Dean W — Stanford University
- Study coordinator: Felsher, Dean W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.